Insulet
PODD
#986
Rank
A$31.65 B
Marketcap
$451.25
Share price
1.63%
Change (1 day)
53.86%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): A$0.49 Billion

According to Insulet's latest financial reports the company's current earnings are A$1.98 Billion. In 2023 the company made an earning of A$0.39 Billion, an increase over its 2022 earnings that were of A$67.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.49 B27.14%
2023 A$0.39 B481.9%
2022 A$67.46 M-45.24%
2021 A$0.12 B43.35%
2020 A$85.93 M18.51%
2019 A$72.51 M41.16%
2018 A$51.37 M-711.95%
2017 -A$8.4 Million-56.85%
2016 -A$19.46 Million-79.31%
2015 -A$94.06 Million63.85%
2014 -A$57.41 Million31.04%
2013 -A$43.81 Million-21.96%
2012 -A$56.14 Million
2010 -A$53.54 Million-42.38%
2009 -A$92.92 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$84.28 Million209.75%
2006 -A$27.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$6.03 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.2 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.19 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.30 B 5,069.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.60 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.26 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$15.88 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA